𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Unfavorable prognosis of breast cancer associated with hyperprolactinemia

Book ID
122690496
Publisher
Elsevier Science
Year
1982
Weight
142 KB
Volume
18
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Methylation of cystatin M promoter is as
Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer
✍ Magdalini Kioulafa; Ioanna Balkouranidou; Georgia Sotiropoulou; Loukas Kaklamani πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 158 KB πŸ‘ 1 views

## Abstract The methylation status of cystatin M (__CST6__) gene in breast tumors was investigated and its prognostic significance as a novel breast cancer biomarker was evaluated. Using methylation‐specific PCR (MSP), __CST6__ promoter methylation was examined in 134 formalin fixed paraffin‐embedd

Prognosis of pregnancy-associated breast
Prognosis of pregnancy-associated breast cancer
✍ Jeanne A. Petrek; Ruth Dukoff; Andre Rogatko πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 393 KB πŸ‘ 2 views
Hyperprolactinemia is an indicator of pr
Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer
✍ Wilhelm Holtkamp; Gerd Arno Nagel; Hans-Erik Wander; Helmut Franz Rauschecker; D πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 French βš– 573 KB

## Abstract In a long‐term follow‐up study, prolactin levels were measured in 149 patients with advanced metastatic breast cancer. Control groups included 221 patients with primary operable breast cancer and 150 women with benign breast disease. Hyperprolactinemia (>1,000 mlU/l; HYPRL) occurs in 44